Browsing Category
Pharma Industry News
4750 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Novartis dodges Trump’s drug tariff blitz with $23bn US reshoring plan
Find out how Novartis plans to produce all key medicines in the US through a $23B investment in 10 new and expanded facilities nationwide.
PharmaLogic announces strategic expansion with Agilera deal amid rising demand for nuclear medicine
PharmaLogic moves to acquire Agilera, boosting global radiopharmaceutical CDMO leadership. Find out how this deal reshapes therapeutic manufacturing worldwide.
Granules India completes Senn Chemicals acquisition to expand peptide therapeutics and CDMO services
Find out how Granules India is entering peptide therapeutics and CDMO services with its Swiss acquisition of Senn Chemicals.
Could this malaria drug become a breakthrough babesiosis cure? Yale and 60 Degrees aim to find out
Find out how 60 Degrees Pharmaceuticals and Yale are working to develop tafenoquine as a treatment for babesiosis, a rising tick-borne disease threat.
Trump’s pharma tariff bombshell: Will your medications get more expensive?
Trump targets global drugmakers with tariffs to boost U.S. manufacturing—but could prices soar? Find out what this move means for pharma and public health.
Avidity Biosciences’ del-desiran granted orphan drug designation in Japan for myotonic dystrophy type 1
Find out how Avidity Biosciences' del-desiran could transform treatment for myotonic dystrophy type 1 after securing Japan's first Orphan Drug nod for DM1.
Gland Pharma wins key FDA nod for $55m painkiller drug, but stock slips after initial surge
Gland Pharma secures US FDA approval for Acetaminophen Injection as its stock sees volatility. Find out what this means for investors and market strategy.
Imfinzi gains EU approval in resectable NSCLC, bolstering AstraZeneca’s oncology pipeline
AstraZeneca’s Imfinzi-based regimen approved in the EU to cut lung cancer recurrence by 32%—learn how this could redefine early-stage NSCLC treatment.
EU approves Enhertu as first HER2-targeted therapy for HR-positive, HER2-low metastatic breast cancer
Discover how Enhertu’s EU approval is transforming care for HR-positive, HER2-low and HER2-ultralow breast cancer, and what it means for AstraZeneca’s future.
Sai Life Sciences unveils cutting-edge Peptide Research Center to fuel biotech breakthroughs
Sai Life Sciences launches Peptide Research Center in Hyderabad to expand peptide therapeutics and R&D services. Learn how this impacts pharma innovation and investors.